Inheriting classics, advancing with the times, standardizing and improving the overall treatment of Parkinson′s disease: at the time of the publication of the Chinese guidelines for the treatment of Parkinson′s disease (fourth edition) / 中华神经科杂志

ABSTRACT

The Chinese guidelines for the treatment of Parkinson′s disease (fourth edition) inherits the essence of the third edition, confirming the therapeutic principles of the third edition, which emphasizes that “Once early diagnosis is made， treatment should be started as soon as possible to grasp the opportunity of disease modification”. It also proposes the concept of “not deliberately delay the use of levodopa”, and pays more attention to non-motor symptoms. The importance of multi-disciplinary team in the overall and whole-process management of Parkinson′s disease is emphasized. According to evidence-based medicine and recommendations in recent years, and based on clinical practice, the new guideline elaborates the concept in depth, including classical treatment, drug use, update of treatment concept, new technology and new method. Moreover, it updates initial and subsequent therapy according to the clinical characteristics, enhances practicality of the guideline, and plays a critical role in further standardizing and improving the level of the overall treatment of Parkinson′s disease in China.